Compare CRL & TY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CRL | TY |
|---|---|---|
| Founded | 1947 | 1929 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 1.7B |
| IPO Year | 2000 | N/A |
| Metric | CRL | TY |
|---|---|---|
| Price | $160.28 | $33.21 |
| Analyst Decision | Buy | |
| Analyst Count | 12 | 0 |
| Target Price | ★ $205.27 | N/A |
| AVG Volume (30 Days) | ★ 854.2K | 43.0K |
| Earning Date | 02-18-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 4.78 |
| Revenue | ★ $4,023,704,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.70 | N/A |
| P/E Ratio | ★ N/A | $6.38 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $91.86 | $25.16 |
| 52 Week High | $228.88 | $30.73 |
| Indicator | CRL | TY |
|---|---|---|
| Relative Strength Index (RSI) | 24.30 | 47.40 |
| Support Level | $148.34 | $33.07 |
| Resistance Level | $218.69 | $33.69 |
| Average True Range (ATR) | 9.40 | 0.34 |
| MACD | -6.28 | 0.00 |
| Stochastic Oscillator | 16.17 | 32.18 |
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Tri-Continental Corp is a United States-based closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.